InsidersTradesSigma
Follow the 睿智医药 stock price and the full insider trade history of the company, a listed issuer based in China. Shares trade on the CN market, under the authority of SSE / SZSE (CSRC). Operating in the Health Care sector, 睿智医药 has logged 1 reports. Market capitalisation: €4.3bn. The latest transaction was reported on 9 August 2021 (Purchase). Among the most active insiders: 齐家辉. All data is accessible without an account.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
睿智医药 is a company focused on the health and pharmaceutical sector, providing innovative solutions for disease treatment. It is listed on the XSHE market.